HOWL
Werewolf Therapeutics
$1.10
+$0.04 (+3.77%)Oct 29, 2026
Key metrics
The numbers that frame HOWL today
- Market cap
- $53.46M
- Gross margin
- 100%
- EV / Sales
- 1.5
- ROIC
- -237.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.27
- 52wk High
- $1.62
Growth
Revenue and earnings trend for HOWL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HOWL
Is Werewolf Therapeutics a good buy?
Yes. Werewolf Therapeutics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks mixed. The support signal is useful, but not decisive. We think Werewolf Therapeutics is selling at a very high price, which cuts against the buy case.
What is the market capitalization of HOWL?
Werewolf Therapeutics's market capitalization is $53.46M.
What is the 52-week high for HOWL stock?
The 52-week high for Werewolf Therapeutics is $1.62. The current close of $1.10 is 32.1% below that high.
What is the 52-week low for HOWL stock?
The 52-week low for Werewolf Therapeutics is $0.27. The current close of $1.10 is 307.4% above that low.
Does HOWL stock pay dividends?
Werewolf Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HOWL?
Werewolf Therapeutics's Debt / Equity ratio is 0.